Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

01 Jul 2019 --- Fourteen varieties of oligosaccharides – a type of prebiotic that aids the growth of beneficial bacteria and protects against harmful varieties in the gut... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jun 2019 --- Dietary fibers are enjoying a place in the health spotlight thanks to the growing body of scientific evidence supporting their contribution to a lowered risk of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Jun 2019 --- Micronutrient deficiencies are common at the time of celiac disease diagnosis in adults, according to a new study by Mayo Clinic researchers. These deficiencies,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Jun 2019 --- With two-thirds of consumers in Europe and the US saying that digestive health is very important to them, products that tout gut-health continue to be on trend. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

20 Jun 2019 --- Children with food allergies have higher subcutaneous levels of advanced glycation end products (AGEs) than children with respiratory allergies, or those with no... Read More

trans